334 related articles for article (PubMed ID: 11592850)
1. Impaired glutamate uptake in the R6 Huntington's disease transgenic mice.
Liévens JC; Woodman B; Mahal A; Spasic-Boscovic O; Samuel D; Kerkerian-Le Goff L; Bates GP
Neurobiol Dis; 2001 Oct; 8(5):807-21. PubMed ID: 11592850
[TBL] [Abstract][Full Text] [Related]
2. Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation.
Behrens PF; Franz P; Woodman B; Lindenberg KS; Landwehrmeyer GB
Brain; 2002 Aug; 125(Pt 8):1908-22. PubMed ID: 12135980
[TBL] [Abstract][Full Text] [Related]
3. Differential expression patterns of three glutamate transporters (GLAST, GLT1 and EAAC1) in the rat main olfactory bulb.
Utsumi M; Ohno K; Onchi H; Sato K; Tohyama M
Brain Res Mol Brain Res; 2001 Aug; 92(1-2):1-11. PubMed ID: 11483236
[TBL] [Abstract][Full Text] [Related]
4. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P
J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1).
Dowd LA; Coyle AJ; Rothstein JD; Pritchett DB; Robinson MB
Mol Pharmacol; 1996 Mar; 49(3):465-73. PubMed ID: 8643086
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of GLT-1 in the R6/2 model of Huntington's disease does not worsen disease progression.
Petr GT; Schultheis LA; Hussey KC; Sun Y; Dubinsky JM; Aoki C; Rosenberg PA
Eur J Neurosci; 2013 Aug; 38(3):2477-90. PubMed ID: 23586612
[TBL] [Abstract][Full Text] [Related]
7. Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking.
Hughes EG; Maguire JL; McMinn MT; Scholz RE; Sutherland ML
Brain Res Mol Brain Res; 2004 May; 124(2):114-23. PubMed ID: 15135219
[TBL] [Abstract][Full Text] [Related]
8. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects.
Faideau M; Kim J; Cormier K; Gilmore R; Welch M; Auregan G; Dufour N; Guillermier M; Brouillet E; Hantraye P; Déglon N; Ferrante RJ; Bonvento G
Hum Mol Genet; 2010 Aug; 19(15):3053-67. PubMed ID: 20494921
[TBL] [Abstract][Full Text] [Related]
9. Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms.
Bradford J; Shin JY; Roberts M; Wang CE; Li XJ; Li S
Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22480-5. PubMed ID: 20018729
[TBL] [Abstract][Full Text] [Related]
10. Altered expressions of glutamate transporter subtypes in rat model of neonatal cerebral hypoxia-ischemia.
Fukamachi S; Furuta A; Ikeda T; Ikenoue T; Kaneoka T; Rothstein JD; Iwaki T
Brain Res Dev Brain Res; 2001 Dec; 132(2):131-9. PubMed ID: 11744117
[TBL] [Abstract][Full Text] [Related]
11. Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms.
Hebb AL; Robertson HA; Denovan-Wright EM
Neuroscience; 2004; 123(4):967-81. PubMed ID: 14751289
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of glutamate transporters in genetic absence epilepsy rats before seizure occurrence.
Dutuit M; Touret M; Szymocha R; Nehlig A; Belin MF; Didier-Bazès M
J Neurochem; 2002 Mar; 80(6):1029-38. PubMed ID: 11953453
[TBL] [Abstract][Full Text] [Related]
13. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of glutamate transporters under hypoxic conditions in vitro.
Hsu L; Rockenstein E; Mallory M; Hashimoto M; Masliah E
J Neurosci Res; 2001 Apr; 64(2):193-202. PubMed ID: 11288147
[TBL] [Abstract][Full Text] [Related]
15. Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease.
Meunier C; Merienne N; Jollé C; Déglon N; Pellerin L
Glia; 2016 Nov; 64(11):1841-56. PubMed ID: 27442486
[TBL] [Abstract][Full Text] [Related]
16. Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen.
Pawlak J; Brito V; Küppers E; Beyer C
Brain Res Mol Brain Res; 2005 Jul; 138(1):1-7. PubMed ID: 15896872
[TBL] [Abstract][Full Text] [Related]
17. R6/2 neurons with intranuclear inclusions survive for prolonged periods in the brains of chimeric mice.
Reiner A; Del Mar N; Deng YP; Meade CA; Sun Z; Goldowitz D
J Comp Neurol; 2007 Dec; 505(6):603-29. PubMed ID: 17948889
[TBL] [Abstract][Full Text] [Related]
18. Nigrostriatal denervation does not affect glutamate transporter mRNA expression but subsequent levodopa treatment selectively increases GLT1 mRNA and protein expression in the rat striatum.
Liévens JC; Salin P; Nieoullon A; Kerkerian-Le Goff L
J Neurochem; 2001 Nov; 79(4):893-902. PubMed ID: 11723182
[TBL] [Abstract][Full Text] [Related]
19. Neuronal glutamate transporter EAAT4 is expressed in astrocytes.
Hu WH; Walters WM; Xia XM; Karmally SA; Bethea JR
Glia; 2003 Oct; 44(1):13-25. PubMed ID: 12951653
[TBL] [Abstract][Full Text] [Related]
20. Glutamate transporter protein subtypes are expressed differentially during rat CNS development.
Furuta A; Rothstein JD; Martin LJ
J Neurosci; 1997 Nov; 17(21):8363-75. PubMed ID: 9334410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
